INCYTE CORPORATION Operating Cash Flow
INCYTE CORPORATION (INCY) reported Operating Cash Flow of $369.35 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-04-28
- INCYTE CORPORATION net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $369.35M, a 38.82% increase year-over-year.
- INCYTE CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $543.30M, a 42.52% increase year-over-year.
- INCYTE CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $559.39M, a 79.94% increase year-over-year.
- INCYTE CORPORATION net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was $44.74M.
- INCYTE CORPORATION net cash provided by (used in) operating activities for fiscal 2025 was $1.41B, a 321.52% increase from fiscal 2024.
- INCYTE CORPORATION net cash provided by (used in) operating activities for fiscal 2024 was $335.34M, a 32.46% decline from fiscal 2023.
- INCYTE CORPORATION net cash provided by (used in) operating activities for fiscal 2023 was $496.49M, a 48.81% decline from fiscal 2022.
- INCYTE CORPORATION net cash provided by (used in) operating activities for fiscal 2022 was $969.94M, a 29.41% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-03-31 | $369.35M 10-Q · filed 2026-04-28 | $912.65M derived: sum of 2 quarters · filed 2026-04-28 | $1.47B derived: sum of 3 quarters · filed 2026-04-28 | $1.52B derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $543.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $1.10B derived: sum of 2 quarters · filed 2026-02-10 | $1.15B derived: sum of 3 quarters · filed 2026-02-10 | $1.41B 10-K · filed 2026-02-10 |
| 2025-09-30 | $559.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $604.13M derived: sum of 2 quarters · filed 2025-10-28 | $870.20M 10-Q · filed 2025-10-28 | $1.25B derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-06-30 | $44.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $310.81M 10-Q · filed 2025-07-29 | $692.03M derived: sum of 3 quarters · filed 2026-04-28 | $1.00B derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-03-31 | $266.07M 10-Q · filed 2026-04-28 | $647.28M derived: sum of 2 quarters · filed 2026-04-28 | $958.16M derived: sum of 3 quarters · filed 2026-04-28 | $382.59M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $381.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $692.09M derived: sum of 2 quarters · filed 2026-02-10 | $116.53M derived: sum of 3 quarters · filed 2026-02-10 | $335.34M 10-K · filed 2026-02-10 |
| 2024-09-30 | $310.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$264.69M derived: sum of 2 quarters · filed 2025-10-28 | -$45.88M 10-Q · filed 2025-10-28 | $101.85M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | -$575.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | -$356.75M 10-Q · filed 2025-07-29 | -$209.02M derived: sum of 3 quarters · filed 2026-02-10 | -$61.19M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $218.81M 10-Q · filed 2025-04-29 | $366.54M derived: sum of 2 quarters · filed 2026-02-10 | $514.38M derived: sum of 3 quarters · filed 2026-02-10 | $820.90M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $147.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $295.56M derived: sum of 2 quarters · filed 2026-02-10 | $602.09M derived: sum of 3 quarters · filed 2026-02-10 | $496.49M 10-K · filed 2026-02-10 |
| 2023-09-30 | $147.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $454.36M derived: sum of 2 quarters · filed 2024-10-29 | $348.76M 10-Q · filed 2024-10-29 | $632.42M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $306.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $200.92M 10-Q · filed 2024-07-30 | $484.58M derived: sum of 3 quarters · filed 2025-02-10 | $780.97M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | -$105.60M 10-Q · filed 2024-04-30 | $178.06M derived: sum of 2 quarters · filed 2025-02-10 | $474.44M derived: sum of 3 quarters · filed 2025-02-10 | $648.60M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $283.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $580.04M derived: sum of 2 quarters · filed 2025-02-10 | $754.20M derived: sum of 3 quarters · filed 2025-02-10 | $969.94M 10-K · filed 2025-02-10 |
| 2022-09-30 | $296.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $470.54M derived: sum of 2 quarters · filed 2023-10-31 | $686.28M 10-Q · filed 2023-10-31 | $801.63M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | $174.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $389.90M 10-Q · filed 2023-08-01 | $505.25M derived: sum of 3 quarters · filed 2024-02-13 | $760.35M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | $215.74M 10-Q · filed 2023-05-02 | $331.09M derived: sum of 2 quarters · filed 2024-02-13 | $586.19M derived: sum of 3 quarters · filed 2024-02-13 | $759.13M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | $115.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $370.45M derived: sum of 2 quarters · filed 2024-02-13 | $543.39M derived: sum of 3 quarters · filed 2024-02-13 | $749.49M 10-K · filed 2024-02-13 |
| 2021-09-30 | $255.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $428.04M derived: sum of 2 quarters · filed 2022-11-01 | $634.14M 10-Q · filed 2022-11-01 | $741.46M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $172.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $379.04M 10-Q · filed 2022-08-02 | $486.36M derived: sum of 3 quarters · filed 2023-02-07 | $668.48M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $206.09M 10-Q · filed 2022-05-03 | $313.42M derived: sum of 2 quarters · filed 2023-02-07 | $495.53M derived: sum of 3 quarters · filed 2023-02-07 | $764.91M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $107.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $289.44M derived: sum of 2 quarters · filed 2023-02-07 | $558.82M derived: sum of 3 quarters · filed 2023-02-07 | -$124.60M 10-K · filed 2023-02-07 |
| 2020-09-30 | $182.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $451.50M derived: sum of 2 quarters · filed 2021-11-02 | -$231.92M 10-Q · filed 2021-11-02 | -$100.30M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $269.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$414.04M 10-Q · filed 2021-08-03 | -$282.42M derived: sum of 3 quarters · filed 2022-02-08 | -$12.00M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | -$683.42M 10-Q · filed 2021-05-04 | -$551.80M derived: sum of 2 quarters · filed 2022-02-08 | -$281.38M derived: sum of 3 quarters · filed 2022-02-08 | -$128.42M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $131.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $402.03M derived: sum of 2 quarters · filed 2022-02-08 | $554.99M derived: sum of 3 quarters · filed 2022-02-08 | $710.66M 10-K · filed 2022-02-08 |
| 2019-09-30 | $270.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $423.38M derived: sum of 2 quarters · filed 2020-11-05 | $579.04M 10-Q · filed 2020-11-05 | $662.88M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $152.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $308.62M 10-Q · filed 2020-08-04 | $392.46M derived: sum of 3 quarters · filed 2021-02-09 | $591.61M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $155.66M 10-Q · filed 2020-05-05 | $239.50M derived: sum of 2 quarters · filed 2021-02-09 | $438.65M derived: sum of 3 quarters · filed 2021-02-09 | $471.05M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $83.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $282.99M derived: sum of 2 quarters · filed 2021-02-09 | $315.39M derived: sum of 3 quarters · filed 2021-02-09 | $336.23M 10-K · filed 2021-02-09 |
| 2018-09-30 | $199.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | $231.55M derived: sum of 2 quarters · filed 2019-10-29 | $252.39M 10-Q · filed 2019-10-29 | $163.12M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $32.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | $53.24M 10-Q · filed 2019-07-30 | -$36.03M derived: sum of 3 quarters · filed 2020-02-13 | $17.10M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $20.84M 10-Q · filed 2019-04-30 | -$68.43M derived: sum of 2 quarters · filed 2020-02-13 | -$15.31M derived: sum of 3 quarters · filed 2020-02-13 | $101.49M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$89.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$36.14M derived: sum of 2 quarters · filed 2020-02-13 | $80.65M derived: sum of 3 quarters · filed 2020-02-13 | -$92.99M 10-K · filed 2020-02-13 |
| 2017-09-30 | $53.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $169.92M derived: sum of 2 quarters · filed 2018-10-30 | -$3.72M 10-Q · filed 2018-10-30 | $90.66M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $116.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$56.84M 10-Q · filed 2018-07-31 | $37.53M derived: sum of 3 quarters · filed 2019-02-14 | $132.81M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | -$173.64M 10-Q · filed 2018-05-01 | -$79.26M derived: sum of 2 quarters · filed 2019-02-14 | $16.01M derived: sum of 3 quarters · filed 2019-02-14 | |
| 2016-12-31 | $94.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $189.65M derived: sum of 2 quarters · filed 2019-02-14 | $304.76M 10-K · filed 2019-02-14 | |
| 2016-09-30 | $95.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $210.38M 10-Q · filed 2017-10-31 | ||
| 2016-06-30 | $115.11M 10-Q · filed 2017-08-01 | |||
| 2015-12-31 | $89.41M 10-K · filed 2018-02-15 | |||
| 2011-06-30 | -$30.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$74.96M 10-Q · filed 2011-07-28 | ||
| 2011-03-31 | -$44.22M 10-Q · filed 2011-05-03 | |||
| 2010-06-30 | -$2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $100.06M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $102.82M 10-Q · filed 2011-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |